Revue medicale suisse

Using intravenous ketamine for patients in a suicidal crisis: when and how they are referred

Updated

Abstract

Intravenous (IV) ketamine may rapidly reduce suicidal ideation and psychological distress within hours.

  • IV ketamine is a therapeutic option specifically for treatment-resistant depression and acute suicidal crisis.
  • Its effects are distinct from conventional antidepressants, which typically take longer to act.
  • Hospital-based care is necessary for its administration, involving medical monitoring and psychiatric assessment.
  • The article outlines indications and referral criteria for primary care physicians regarding IV ketamine use.

Simplified

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free